Posted Nov. 11, 2013 at 1:30 p.m.

Premium Lock Changing times: GSK sells bad with good to doctors in safety push

Published: 2013-11-11 13:30:00
Updated: 2013-11-11 13:30:00


When 100 of the top lung doctors in the U.S. gathered in Houston recently to learn about GlaxoSmithKline's new respiratory drug, one message rang loud and clear: Don't ignore the pneumonia risk. It's part of a new "Patient First" strategy from GSK....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders